Skip to main content

Table 3 UVA for overall, distant-metastasis free, and progression-free survival

From: Smoking is predictive of poorer distant metastasis-free and progression free-survival in soft tissue sarcoma patients treated with pre-operative radiotherapy or chemoradiotherapy

Variable

p-value

OS

DMFS

PFS

Age

0.0005

0.0218

NS

Smoking

0.05

0.0038

0.0151

Cardiovascular disease

NS

NS

NS

Diabetes

NS

NS

NS

High-grade

0.04

0.04

NS

Histology

NS

0.02

NS

Karnofsky performance status

NS

NS

NS

Tumor location

0.03

NS

0.0116

Tumor size

0.008

0.0088

0.0012

Chemotherapy

NS

NS

NS

  1. NS not-significant